5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2 |
_version_ | 1797279709554278400 |
---|---|
author | P. Bartolucci K.I. Ataga M. Callaghan L. De Franceschi C. Minniti A. Alexandrou D.-.C. Imbs R.P. Fox H. Patel A. Sostelly J. Schimmel |
author_facet | P. Bartolucci K.I. Ataga M. Callaghan L. De Franceschi C. Minniti A. Alexandrou D.-.C. Imbs R.P. Fox H. Patel A. Sostelly J. Schimmel |
author_sort | P. Bartolucci |
collection | DOAJ |
first_indexed | 2024-03-07T16:30:52Z |
format | Article |
id | doaj.art-caf22b796a8b4e06b2960cf7684fe49f |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:30:52Z |
publishDate | 2023-04-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-caf22b796a8b4e06b2960cf7684fe49f2024-03-03T11:20:30ZengWileyHemaSphere2572-92412023-04-017S1222210.1097/01.HS9.0000928292.81037.b2202304001-000415610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)P. BartolucciK.I. AtagaM. CallaghanL. De FranceschiC. MinnitiA. AlexandrouD.-.C. ImbsR.P. FoxH. PatelA. SostellyJ. Schimmelhttp://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2 |
spellingShingle | P. Bartolucci K.I. Ataga M. Callaghan L. De Franceschi C. Minniti A. Alexandrou D.-.C. Imbs R.P. Fox H. Patel A. Sostelly J. Schimmel 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) HemaSphere |
title | 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full | 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_fullStr | 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full_unstemmed | 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_short | 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_sort | 5610823 trial in progress the randomized double blind placebo controlled phase 1b crosswalk a trial evaluating the safety of crovalimab for the management of acute uncomplicated vaso occlusive episodes voes in patients pts with sickle cell disease scd |
url | http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2 |
work_keys_str_mv | AT pbartolucci 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT kiataga 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT mcallaghan 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT ldefranceschi 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT cminniti 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT aalexandrou 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT dcimbs 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT rpfox 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT hpatel 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT asostelly 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT jschimmel 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd |